Biomarkers
Measurable biological indicators used by AI models to assess health and disease.
Biomarkers are quantifiable biological signals — ranging from blood proteins and genetic sequences to imaging features and behavioral patterns — that encode meaningful information about an individual's physiological state. In machine learning contexts, biomarkers serve as input features for predictive models trained to detect disease, stratify patient risk, monitor treatment response, or forecast clinical outcomes. Their value lies in their objectivity and measurability: unlike subjective clinical assessments, biomarkers can be systematically collected, standardized, and fed into algorithms at scale.
ML models leverage biomarkers in several ways. Supervised learning systems trained on labeled patient cohorts can learn which combinations of biomarkers predict conditions such as cancer, cardiovascular disease, or neurodegeneration — often identifying subtle multivariate patterns invisible to human clinicians. Deep learning models applied to medical imaging extract high-dimensional imaging biomarkers (radiomics features) that capture tumor texture, shape, and heterogeneity. Similarly, genomic and proteomic biomarkers feed into models for drug response prediction and patient stratification in clinical trials. The explosion of electronic health records and high-throughput omics technologies in the 2010s dramatically expanded the volume and variety of biomarker data available for model training.
The integration of biomarkers into AI-driven healthcare has become a cornerstone of precision medicine — the paradigm of tailoring treatment to individual biological profiles rather than population averages. Models combining multi-modal biomarkers (imaging, genomic, clinical lab values) consistently outperform single-modality approaches, motivating ongoing research into data fusion architectures. Challenges include biomarker variability across measurement platforms, missing data in real-world clinical settings, and the need for rigorous validation before deployment in clinical decision support systems.
Beyond traditional healthcare, biomarkers are increasingly relevant in wearable-device ML pipelines, where physiological signals such as heart rate variability, skin conductance, and accelerometry serve as behavioral and metabolic biomarkers for continuous health monitoring. As sensor technology and model interpretability improve, AI systems built on biomarker data are expected to shift medicine further toward proactive, personalized, and preventive care.
